Variant report
Variant | esv3442909 |
---|---|
Chromosome Location | chr13:87529651-87531799 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:87530439..87532752-chr13:87534404..87536619,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35969347 | chr13:87529670-87529671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs72635379 | chr13:87529719-87529720 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs527825528 | chr13:87529767-87529768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534690656 | chr13:87529810-87529811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs571802794 | chr13:87529840-87529841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs201690320 | chr13:87529870-87529871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552660505 | chr13:87529951-87529952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs74999556 | chr13:87529965-87529966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545422125 | chr13:87529984-87529985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112898802 | chr13:87530065-87530066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186911209 | chr13:87530097-87530098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs77762426 | chr13:87530110-87530111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537053163 | chr13:87530113-87530114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368962509 | chr13:87530178-87530179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146714715 | chr13:87530309-87530310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71799201 | chr13:87530310-87530311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536134882 | chr13:87530329-87530330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs3071234 | chr13:87530333-87530334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557640492 | chr13:87530377-87530378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554591134 | chr13:87530380-87530381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572466456 | chr13:87530425-87530426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539944471 | chr13:87530442-87530443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139496426 | chr13:87530461-87530462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149698001 | chr13:87530472-87530473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs60137476 | chr13:87530475-87530476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs35490816 | chr13:87530476-87530477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs71445371 | chr13:87530478-87530479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs199767429 | chr13:87530481-87530482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs145540060 | chr13:87530485-87530486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148888045 | chr13:87530486-87530487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs373830606 | chr13:87530541-87530542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201442598 | chr13:87530543-87530544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7990913 | chr13:87530545-87530546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs56406625 | chr13:87530573-87530574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs59178534 | chr13:87530574-87530575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138194857 | chr13:87530590-87530591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34855417 | chr13:87530612-87530613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs56160406 | chr13:87530628-87530629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530474375 | chr13:87530635-87530636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574272089 | chr13:87530664-87530665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563101889 | chr13:87530737-87530738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542992245 | chr13:87530751-87530752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs13378877 | chr13:87530754-87530755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527636170 | chr13:87530774-87530775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187053725 | chr13:87530785-87530786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7991299 | chr13:87530794-87530795 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs149118013 | chr13:87530811-87530812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550780108 | chr13:87530845-87530846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150387719 | chr13:87530888-87530889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs13378883 | chr13:87530948-87530949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:87529600-87530200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr13:87529600-87530200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr13:87530200-87532200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr13:87530200-87532800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |